Siga Technologies Inc. (SIGA, Financial) experienced a notable stock price drop of 5.01%, currently valued at $7.16 per share. The trading volume reached 223,700 shares, equating to a turnover rate of 0.31% and a price fluctuation of 5.84%.
According to recent financial reports, Siga Technologies achieved revenue of $10.01 million and a net profit of $1.34 million, resulting in earnings per share of $0.02. The company's gross profit stood at $8.39 million, with a price-to-earnings ratio of 5.95. No institutional ratings for buying, holding, or selling have been provided for SIGA at this time.
Within the pharmaceutical sector, which saw an overall decline of 1.11%, some related stocks had notable performances. Biofrontera Inc C/Wts 27/10/2026 (To Pur Com), Biofrontera Inc., and Cronos Group Inc. Common Share posted significant gains. Meanwhile, Rockwell Medical, Inc., Sonoma Pharmaceuticals, Inc., and Canopy Growth Corporation showed higher activity levels with turnover rates of 16.70%, 13.75%, and 11.41%, respectively. Companies such as Cyclo Therapeutics Inc C/Wts 11/12/2025 (To Pur Com) and Biofrontera Inc C/Wts 27/10/2026 (To Pur Com) displayed large stock price fluctuations.
Siga Technologies Inc. is a commercial-stage pharmaceutical company focusing on the health security market. Its primary product is TPOXX, an oral antiviral treatment for smallpox. The majority of the company's revenue is generated in the U.S.
